Protection of cellular and mitochondrial functions against liver ischemia by N-benzyl-N′-(2-hydroxy-3,4-dimethoxybenzyl)-piperazine (BHDP), a sigma1 ligand

European Journal of Pharmacology

Volumn 578, Issue 2-3, 2008, Pages 292-299

  Klouz, Anis ^a   Saïd, Dorra Ben ^a   Ferchichi, Henda ^a   Kourda, Nadia ^b   Ouanes, Lobna ^a   Lakhal, Mohamed ^a   Tillement, Jean Paul ^c   Morin, Didier ^c,d  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

^c FACULTÉ DE MÉDECINE   (France)

^d INSERM   (France)

Author keywords

BHDP; Hypothermic preservation; Liver; Mitochondria; Monoethylglycinexylidide; Normothermic ischemia reperfusion

Indexed keywords

LIGAND; N BENZYL N' (2 HYDROXY 3,4 DIMETHOXYBENZYL) PIPERAZINE; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL FUNCTION; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; LIVER ISCHEMIA; MALE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOTRANSFORMATION; CELL MEMBRANE; CELL RESPIRATION; COLD ISCHEMIA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; LIDOCAINE; LIGANDS; LIVER; MALE; MITOCHONDRIA, LIVER; PIPERAZINES; PROTECTIVE AGENTS; RATS; RATS, WISTAR; RECEPTORS, SIGMA; REPERFUSION INJURY; TIME FACTORS;

EID: 37349013507     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.09.038     Document Type: Article

References (30)

1. Albengres E., Tillement J.P., Le Louet H., and Morin D. Trimetazidine: experimental and clinical update review. Cardiovasc. Drug Rev. 16 (1998) 359-390
2. Alexson S.E., Diczfalusy M., Halldin M., and Swedmark S. Involvement of liver carboxylesterases in the in vitro metabolism of lidocaine. Drug Metab. Dispos. 30 (2002) 643-647
3. Camargo Jr. C.A., Madden J.F., Gao W., Selvan R.S., and Clavien P.A. Interleukin-6 protects liver against warm ischaemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26 (1997) 1513-1520
4. Cassidy W.M., and Reynolds T.B. Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. J. Clin. Gastroenterol. 19 (1994) 118-121
5. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341 (1999) 233-249
6. Duval M., Plin C., Elimadi A., Vallerand D., Tillement J.P., Morin D., and Haddad P.S. Implication of mitochondrial dysfunction and cell death in cold preservation-warm reperfusion-induced hepatocyte injury. Can. J. Physiol. Pharm. 84 (2006) 547-554
7. Elimadi A., Settaf A., Morin D., Sapena R., Lamchouri F., Cherrah Y., and Tillement J.P. Trimetazidine counteracts the hepatic injury associated with ischaemia-reperfusion by preserving mitochondrial function. J. Pharmacol. Exp. Ther. 286 (1998) 23-28
8. Elimadi A., Sapena R., Settaf A., Le Louet H., Tillement J.P., and Morin D. Attenuation of liver normothermic ischemia-reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative. Biochem. Pharmacol. 62 (2001) 509-516
9. Faure J.P., Jayle C., Dutheil D., Eugene M., Zhang K., Goujon J.M., Petit-Paris I., Tillement J.P., Touchard G., Robert R., Wahl A., Seguin F., Mauco G., Vandewalle A., and Hauet T. Evidence for protective roles of polyethylene glycol plus high sodium solution and trimetazidine against consequences of renal medulla ischaemia during cold preservation and reperfusion in a pig kidney model. Nephrol. Dial. Transplant. 19 (2004) 1742-1751
10. Gawronska-Szklarz B., Musial H.D., Loniewski I., Paprota B., and Drozdzik M. Lidocaine metabolism in isolated perfused liver from streptozotocin-induced diabetic rats. J. Pharm. Pharmacol. 58 (2006) 1073-1077
11. Goyagi T., Goto S., Bhardwaj A., Dawson V.L., Hurn P.D., and Kirsch J.R. Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. Stroke 32 (2001) 1613-1620
12. Grattagliano I., Vendemiale G., and Lauterburg B.H. Reperfusion injury of the liver: role of mitochondria and protection by glutathione ester. J. Surg. Res. 86 (1999) 2-8
13. Huang Y.S., Lee S.D., Deng J.F., Wu J.C., Lu R.H., Lin Y.F., Wang Y.J., and Lo K.J. Measuring lidocaine metabolite-monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis. J. Hepatol. 19 (1993) 140-147
14. Johnson D., and Lardy H.A. Isolation of liver and kidney mitochondria. In: Estabook R.W., and Pullman M. (Eds). Methods in Enzymology (1967), Academic Press, NewYork 94-96
15. Karwinski W., Garcia R., and Helton W.S. Protective effects of the calcium channel blocker verapamil on hepatic function following warm ischemia. J. Surg. Res. 64 (1996) 150-155
16. Klouz A., Sapena R., Liu J., Maurice T., Tillement J.P., Papadopoulos V., and Morin D. Evidence for sigma-1-like receptors in isolated rat liver mitochondrial membranes. Br. J. Pharmacol. 135 (2002) 1607-1615
17. Klouz A., Tillement J.P., Boussard M.F., Wierzbicki M., Berezowski V., Cecchelli R., Labidalle S., Onteniente B., and Morin D. [3H]BHDP as a novel and selective ligand for sigma1 receptors in liver mitochondria and brain synaptosomes of the rat. FEBS Lett. 553 (2003) 157-162
18. Kohli V., Selzner M., Madden J.F., Bentley R.C., and Clavien P.A. Endothelial cell and hepatocyte deaths occur by apoptosis after ischaemia-reperfusion injury in the rat liver. Transplantation 67 (1999) 1099-1105
19. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
20. Malhi H., Gores G.J., and Lemasters J.J. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 43 (2006) S31-S44
21. Morin D., Sapena R., Elimadi A., Testa B., Labidalle S., Le Ridant A., and Tillement J.P. [(3)H]-trimetazidine mitochondrial binding sites: regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substance. Br. J. Pharmacol. 130 (2000) 655-663
22. Morin D., Pires F., Plin C., and Tillement J.P. Role of the permeability transition pore in cytochrome C release from mitochondria during ischemia-reperfusion in rat liver. Biochem. Pharmacol. 68 (2004) 2065-2073
23. Nakazawa M., Matsuno K., and Mita S. Activation of sigma1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures. Neurochem. Int. 32 (1998) 337-343
24. Nauta R.J., Uribe M., Walsh D.B., Miller D., and Butterfield A. Description of a chronic in vivo model for the study of warm hepatic ischaemia-reperfusion injury. Surg. Res. Commun. 6 (1989) 241-246
25. Nishizawa H., Egawa H., Inomata Y., Uemoto S., Asonuma K., Kiuchi T., Yamaoka Y., and Tanaka K. Efficiency of pentoxifylline in donor pretreatment in rat liver transplantation. J. Surg. Res. 72 (1997) 170-176
26. Oellerich M., and Amstrong V.W. The MEGX test: a tool for the real-time assessment of hepatic function. Ther. Drug Monit. 23 (2001) 81-92
27. Okuaki Y., Miyazaki H., Zeniya M., Ishikawa T., Ohkawa Y., Tsuno S., Sakaguchi M., Hara M., Takahashi H., and Toda G. Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat. Liver 16 (1996) 188-194
28. Plin C., Tillement J.P., Berdeaux A., and Morin D. Resveratrol protects against cold ischemia-warm reoxygenation-induced damages to mitochondria and cells in rat liver. Eur. J. Pharmacol. 528 (2005) 162-168
29. Sakr M.F., Zetti G.M., Hassanein T.I., Farghali H., Nalesnik M.A., Gavaler J.S., Starzl T.E., and Van Thiel D.H. FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. Hepatology 13 (1991) 947-951
30. Yamamoto S., Shimizu K., Oonishi I., Hasebe K., Takamura H., Inoue T., Muraoka K., Tani T., Hashimoto T., and Yagi M. Genistein suppresses cellular injury following hepatic ischemia/reperfusion. Transplant. Proc. 28 (1996) 1111-1115